An observational study in Glaucoma, Glaucoma, Open-Angle and Glaucoma, Angle-Closure, sponsored by Technische Universität Dresden. Recruiting at 1 site in Germany. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by Technische Universität Dresden · Observational
To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.
The aim of the study is to evaluate the quality of follow-up and treatment by means of consecutive data collection and anonymised analysis of all glaucoma patients of a tertiary university hospital glaucoma service.
Parameters being analyzed are:
Age, sex, refraction, family history, known duration of glaucoma, highest intraocular pressure before treatment, systemic and topical medication, previous ocular surgery.
24h Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph (HRT), glaucoma diagnosis with Scanning-Laser-Polarimetry (GDx), optical coherence tomography (OCT), Pentacam, Ocular Response Analyzer (ORA), Corvis ST (Corneal Visualization with the Scheimpflug Technology), perimetry
1,419 studies on the registry are indexed under Glaucoma; 223 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 101 across 385 observational studies indexed under Glaucoma.
Browse Glaucoma studies →Technische Universität Dresden is the lead sponsor of 247 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Glaucoma patients attending a tertiary University Hospital glaucoma Service.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Follow-up intervals
To find the best follow-up intervals for glaucoma patients.
Time frame: 20 years
Assessment of treatment quality
What is the best treatment option for the individual patient?
Time frame: 20 years
Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy
Diurnal intraocular pressure, best corrected visual acuity, visual fields
Time frame: 20 years
Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy of glaucoma surgery
Diurnal intraocular pressure, best corrected visual acuity, visual fields
Time frame: 20 years
Plan to share: No — Individual participant data are only shared between researchers of our Institute.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Technische Universität Dresden →